Advanced SearchSearch Tips
From cell senescence to age-related diseases: differential mechanisms of action of senescence-associated secretory phenotypes
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : BMB Reports
  • Volume 48, Issue 10,  2015, pp.549-558
  • Publisher : Korean Society for Biochemistry and Molecular Biology
  • DOI : 10.5483/BMBRep.2015.48.10.122
 Title & Authors
From cell senescence to age-related diseases: differential mechanisms of action of senescence-associated secretory phenotypes
Byun, Hae-Ok; Lee, Young-Kyoung; Kim, Jeong-Min; Yoon, Gyesoon;
  PDF(new window)
Cellular senescence is a process by which cells enter a state of permanent cell cycle arrest. It is commonly believed to underlie organismal aging and age-associated diseases. However, the mechanism by which cellular senescence contributes to aging and age-associated pathologies remains unclear. Recent studies showed that senescent cells exert detrimental effects on the tissue microenvironment, generating pathological facilitators or aggravators. The most significant environmental effector resulting from senescent cells is the senescence-associated secretory phenotype (SASP), which is constituted by a strikingly increased expression and secretion of diverse pro-inflammatory cytokines. Careful investigation into the components of SASPs and their mechanism of action, may improve our understanding of the pathological backgrounds of age-associated diseases. In this review, we focus on the differential expression of SASP-related genes, in addition to SASP components, during the progress of senescence. We also provide a perspective on the possible action mechanisms of SASP components, and potential contributions of SASP-expressing senescent cells, to age-associated pathologies.
Age-associated diseases;Cell senescence;Differential expression;Senescence-associated secretory phenotypes (SASP);
 Cited by
Aging: Molecular Pathways and Implications on the Cardiovascular System, Oxidative Medicine and Cellular Longevity, 2017, 2017, 1  crossref(new windwow)
Anti-aging pharmacology: Promises and pitfalls, Ageing Research Reviews, 2016, 31, 9  crossref(new windwow)
Effects of ultra-high dilutions of sodium butyrate on viability and gene expression in HEK 293 cells, Homeopathy, 2017, 106, 1, 32  crossref(new windwow)
Ataxia-telangiectasia (A-T): An emerging dimension of premature ageing, Ageing Research Reviews, 2017, 33, 76  crossref(new windwow)
ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age-Related Diseases, Oxidative Medicine and Cellular Longevity, 2016, 2016, 1  crossref(new windwow)
Caveolin-1 deficiency induces premature senescence with mitochondrial dysfunction, Aging Cell, 2017, 16, 4, 773  crossref(new windwow)
Redox control of senescence and age-related disease, Redox Biology, 2017, 11, 91  crossref(new windwow)
Chen D, Yoo BK, Santhekadur PK et al (2011) Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma. Clin Cancer Res 17, 6693-6701 crossref(new window)

Jones AW, Yao Z, Vicencio JM, Karkucinska-Wieckowska A and Szabadkai G (2012) PGC-1 family coactivators and cell fate: roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria-nucleus signalling. Mitochondrion 12, 86-99 crossref(new window)

Chatrchyan S, Khachatryan V, Sirunyan AM et al (2011) Measurement of the inclusive jet cross section in pp collisions at radicals = 7 TeV. Phys Rev Lett 107, 132001 crossref(new window)

Sunderic M, Mihailovic N and Nedic O (2014) Protein molecular forms of insulin-like growth factor binding protein-2 change with aging. Exp Gerontol 58, 154-158 crossref(new window)

Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H and Komuro I (2002) Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105, 1541-1544 crossref(new window)

Youdim MB and Riederer P (1993) The role of iron in senescence of dopaminergic neurons in Parkinson's disease. J Neural Transm Suppl 40, 57-67

Hengstler JG and Bolt HM (2008) Oxidative stress: from modification of cell-cycle related events, secondary messenger function, dysregulation of small GTPases, protein kinases and phosphatases to redox-sensitive cancer models. Arch Toxicol 82, 271-272 crossref(new window)

Jones RM and Neef N (2012) Interpretation and prediction of inhaled drug particle accumulation in the lung and its associated toxicity. Xenobiotica 42, 86-93 crossref(new window)

Hung WY, Huang KH, Wu CW et al (2012) Mitochondrial dysfunction promotes cell migration via reactive oxygen species-enhanced beta5-integrin expression in human gastric cancer SC-M1 cells. Biochim Biophys Acta 1820, 1102-1110 crossref(new window)

Hoffmeister A, Ropolo A, Vasseur S et al (2002) The HMG-I/Y-related protein p8 binds to p300 and Pax2 transactivation domain-interacting protein to regulate the transactivation activity of the Pax2A and Pax2B transcription factors on the glucagon gene promoter. J Biol Chem 277, 22314-22319 crossref(new window)

Rohman L and Jones A (2012) Chilaiditi's sign. Emerg Med J 29, 86 crossref(new window)

Engelberg B and Jones B (2012) Exploring minimally invasive options: managing demands, expectations, and outcomes. Dent Today 31, 86, 88, 90 passim

West MD, Shay JW, Wright WE and Linskens MH (1996) Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence. Exp Gerontol 31, 175-193 crossref(new window)

Lapierre LR and Hansen M (2012) Lessons from C. elegans: signaling pathways for longevity. Trends Endocrinol Metab 23, 637-644 crossref(new window)

Comi P, Chiaramonte R and Maier JA (1995) Senescencedependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells. Exp Cell Res 219, 304-308 crossref(new window)

Sabharwal SS and Schumacker PT (2014) Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? Nat Rev Cancer 14, 709-721 crossref(new window)

Ballinger SW (2013) Beyond retrograde and anterograde signalling: mitochondrial-nuclear interactions as a means for evolutionary adaptation and contemporary disease susceptibility. Biochem Soc Trans 41, 111-117 crossref(new window)

Dimri GP, Lee X, Basile G et al (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92, 9363-9367 crossref(new window)

Bateman A and Bennett HP (2009) The granulin gene family: from cancer to dementia. Bioessays 31, 1245-1254 crossref(new window)

Beckman KB and Ames BN (1999) Endogenous oxidative damage of mtDNA. Mutat Res 424, 51-58 crossref(new window)

Biswas G, Adebanjo OA, Freedman BD et al (1999) Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO J 18, 522-533 crossref(new window)

Biswas G, Anandatheerthavarada HK, Zaidi M and Avadhani NG (2003) Mitochondria to nucleus stress signaling: a distinctive mechanism of NFkappaB/Rel activation through calcineurin-mediated inactivation of IkappaBbeta. J Cell Biol 161, 507-519 crossref(new window)

Berneburg M, Kamenisch Y, Krutmann J and Rocken M (2006) 'To repair or not to repair - no longer a question': repair of mitochondrial DNA shielding against age and cancer. Exp Dermatol 15, 1005-1015 crossref(new window)

He X, Zhou A, Lu H et al (2013) Suppression of mitochondrial complex I influences cell metastatic properties. PLoS One 8, e61677 crossref(new window)

Boiteux S and Radicella JP (2000) The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys 377, 1-8 crossref(new window)

Brandon M, Baldi P and Wallace DC (2006) Mitochondrial mutations in cancer. Oncogene 25, 4647-4662 crossref(new window)

Zhang YQ and Herman B (2008) Expression and modification of ARC (apoptosis repressor with a CARD domain) is distinctly regulated by oxidative stress in cancer cells. J Cell Biochem 104, 818-825 crossref(new window)

Bogenhagen DF, Pinz KG and Perez-Jannotti RM (2001) Enzymology of mitochondrial base excision repair. Prog Nucleic Acid Res Mol Biol 68, 257-271 crossref(new window)

Guettouche T, Boellmann F, Lane WS and Voellmy R (2005) Analysis of phosphorylation of human heat shock factor 1 in cells experiencing a stress. BMC Biochem 6, 4 crossref(new window)

Butow RA and Avadhani NG (2004) Mitochondrial signaling: the retrograde response. Mol Cell 14, 1-15 crossref(new window)

Byun HO, Jung HJ, Seo YH et al (2012) GSK3 inactivation is involved in mitochondrial complex IV defect in transforming growth factor (TGF) beta1-induced senescence. Exp Cell Res 318, 1808-1819 crossref(new window)

Amuthan G, Biswas G, Ananadatheerthavarada HK, Vijayasarathy C, Shephard HM and Avadhani NG (2002) Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene 21, 7839-7849 crossref(new window)

Byun HO, Kim HY, Lim JJ, Seo YH and Yoon G (2008) Mitochondrial dysfunction by complex II inhibition delays overall cell cycle progression via reactive oxygen species production. J Cell Biochem 104, 1747-1759 crossref(new window)

Campagnoni CW, Landry CF, Pribyl TM et al (2001) Identification of genes in the oligodendrocyte lineage through the analysis of conditionally immortalized cell lines. Dev Neurosci 23, 452-463 crossref(new window)

Cano CE, Hamidi T, Sandi MJ and Iovanna JL (2011) Nupr1: the Swiss-knife of cancer. J Cell Physiol 226, 1439-1443 crossref(new window)

Carew JS and Huang P (2002) Mitochondrial defects in cancer. Mol Cancer 1, 9 crossref(new window)

Chae S, Ahn BY, Byun K et al (2013) A systems approach for decoding mitochondrial retrograde signaling pathways. Sci Signal 6, rs4 crossref(new window)

Chang CJ, Yin PH, Yang DM et al (2009) Mitochondrial dysfunction-induced amphiregulin upregulation mediates chemo-resistance and cell migration in HepG2 cells. Cell Mol Life Sci 66, 1755-1765 crossref(new window)

Chatterjee A, Mambo E and Sidransky D (2006) Mitochondrial DNA mutations in human cancer. Oncogene 25, 4663-4674 crossref(new window)

Stein GH and Dulic V (1998) Molecular mechanisms for the senescent cell cycle arrest. J Investig Dermatol Symp Proc 3, 14-18

Hwang ES, Yoon G and Kang HT (2009) A comparative analysis of the cell biology of senescence and aging. Cell Mol Life Sci 66, 2503-2524 crossref(new window)

Cheung ST, Wong SY, Leung KL et al (2004) Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Clin Cancer Res 10, 7629-7636 crossref(new window)

Chowdhury UR, Samant RS, Fodstad O and Shevde LA (2009) Emerging role of nuclear protein 1 (NUPR1) in cancer biology. Cancer Metastasis Rev 28, 225-232 crossref(new window)

Clayton DA (1998) Nuclear-mitochondrial intergenomic communication. Biofactors 7, 203-205 crossref(new window)

Cortopassi G and Wang E (1995) Modelling the effects of age-related mtDNA mutation accumulation; complex I deficiency, superoxide and cell death. Biochim Biophys Acta 1271, 171-176 crossref(new window)

Kim YM, Shin HT, Seo YH et al (2010) Sterol regulatory element-binding protein (SREBP)-1-mediated lipogenesis is involved in cell senescence. J Biol Chem 285, 29069-29077 crossref(new window)

Khachatryan V, Sirunyan AM, Tumasyan A et al (2011) Measurement of the B(+) production cross section in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett 106, 112001 crossref(new window)

Czarnecka AM, Kukwa W, Krawczyk T, Scinska A, Kukwa A and Cappello F (2010) Mitochondrial DNA mutations in cancer--from bench to bedside. Front Biosci 15, 437-460 crossref(new window)

Seo M and Lee YH (2014) PFKFB3 regulates oxidative stress homeostasis via its S-glutathionylation in cancer. J Mol Biol 426, 830-842 crossref(new window)

Millis AJ, Hoyle M, McCue HM and Martini H (1992) Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp Cell Res 201, 373-379 crossref(new window)

Coppe JP, Patil CK, Rodier F et al (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6, 2853-2868 crossref(new window)

Imamura H, Matsuyama Y, Tanaka E et al (2003) Risk fac- tors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38, 200-207 crossref(new window)

Rodier F and Campisi J (2011) Four faces of cellular senescence. J Cell Biol 192, 547-556 crossref(new window)

Vital P, Castro P, Tsang S and Ittmann M (2014) The senescence-associated secretory phenotype promotes benign prostatic hyperplasia. Am J Pathol 184, 721-731 crossref(new window)

Han X and Boisvert WA (2015) Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function. Thromb Haemost 113, 505-512 crossref(new window)

Groppo R and Richter JD (2011) CPEB control of NF-kappaB nuclear localization and interleukin-6 production mediates cellular senescence. Mol Cell Biol 31, 2707-2714 crossref(new window)

Kulju KS and Lehman JM (1995) Increased p53 protein associated with aging in human diploid fibroblasts. Exp Cell Res 217, 336-345 crossref(new window)

Salminen A and Kaarniranta K (2010) Glycolysis links p53 function with NF-kappaB signaling: impact on cancer and aging process. J Cell Physiol 224, 1-6

Brookes S, Rowe J, Gutierrez Del Arroyo A, Bond J and Peters G (2004) Contribution of p16 (INK4a) to replicative senescence of human fibroblasts. Exp Cell Res 298, 549-559 crossref(new window)

Delsite R, Kachhap S, Anbazhagan R, Gabrielson E and Singh KK (2002) Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells. Mol Cancer 1, 6 crossref(new window)

Demorrow S (2013) Progranulin: a novel regulator of gastrointestinal cancer progression. Transl Gastrointest Cancer 2, 145-151

Di Bella D, Lazzaro F, Brusco A et al (2010) Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat Genet 42, 313-321 crossref(new window)

Dzierzbicki P, Koprowski P, Fikus MU, Malc E and Ciesla Z (2004) Repair of oxidative damage in mitochondrial DNA of Saccharomyces cerevisiae: involvement of the MSH1-dependent pathway. DNA Repair (Amst) 3, 403-411 crossref(new window)

DiMauro S and Schon EA (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348, 2656-2668 crossref(new window)

Encinar JA, Mallo GV, Mizyrycki C et al (2001) Human p8 is a HMG-I/Y-like protein with DNA binding activity enhanced by phosphorylation. J Biol Chem 276, 2742-2751 crossref(new window)

Finley LW and Haigis MC (2009) The coordination of nuclear and mitochondrial communication during aging and calorie restriction. Ageing Res Rev 8, 173-188 crossref(new window)

Ashok BT, Ahmad J and Ali R (1998) Immunochemical detection of oxidative DNA damage in cancer and aging using anti-reactive oxygen species modified DNA monoclonal antibody. Int J Biochem Cell Biol 30, 1367-1377 crossref(new window)

Gardiner K (1995) Human genome organization. Curr Opin Genet Dev 5, 315-322 crossref(new window)

Goruppi S, Bonventre JV and Kyriakis JM (2002) Signaling pathways and late-onset gene induction associated with renal mesangial cell hypertrophy. EMBO J 21, 5427-5436 crossref(new window)

Giroux V, Malicet C, Barthet M et al (2006) p8 is a new target of gemcitabine in pancreatic cancer cells. Clin Cancer Res 12, 235-241 crossref(new window)

Goruppi S and Kyriakis JM (2004) The pro-hypertrophic basic helix-loop-helix protein p8 is degraded by the ubiquitin/proteasome system in a protein kinase B/Akt- and glycogen synthase kinase-3-dependent manner, whereas endothelin induction of p8 mRNA and renal mesangial cell hypertrophy require NFAT4. J Biol Chem 279, 20950-20958 crossref(new window)

Gredilla R, Garm C and Stevnsner T (2012) Nuclear and mitochondrial DNA repair in selected eukaryotic aging model systems. Oxid Med Cell Longev 2012, 282438 crossref(new window)

Grollman AP and Moriya M (1993) Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet 9, 246-249 crossref(new window)

Guha M and Avadhani NG (2013) Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics. Mitochondrion 13, 577-591 crossref(new window)

Takahashi T, Yoshida H, Mamada Y, Taniai N and Tajiri T (2009) Balloon-occluded retrograde transvenous obliteration for gastric varices in a child with extrahepatic portal venous obstruction. J Nippon Med Sch 76, 173-178 crossref(new window)

Hamidi T, Algul H, Cano CE et al (2012) Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis. J Clin Invest 122, 2092-2103 crossref(new window)

Hamidi T, Cano CE, Grasso D et al (2012) Nupr1-aurora kinase A pathway provides protection against metabolic stress-mediated autophagic-associated cell death. Clin Cancer Res 18, 5234-5246 crossref(new window)

Haque A, Nishikawa M, Qian W et al (2006) Lack of mitochondrial DNA enhances growth of hepatocellular carcinoma in vitro and in vivo. Hepatol Res 36, 209-216 crossref(new window)

Hashiguchi K, Stuart JA, de Souza-Pinto NC and Bohr VA (2004) The C-terminal alphaO helix of human Ogg1 is essential for 8-oxoguanine DNA glycosylase activity: the mitochondrial beta-Ogg1 lacks this domain and does not have glycosylase activity. Nucleic Acids Res 32, 5596-5608 crossref(new window)

Brew K, Dinakarpandian D and Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477, 267-283 crossref(new window)

Reichenstein M, Reich R, LeHoux JG and Hanukoglu I (2004) ACTH induces TIMP-1 expression and inhibits collagenase in adrenal cortex cells. Mol Cell Endocrinol 215, 109-114 crossref(new window)

Binder BR, Christ G, Gruber F et al (2002) Plasminogen activator inhibitor 1: physiological and pathophysiological roles. News Physiol Sci 17, 56-61

Alessi MC, Poggi M and Juhan-Vague I (2007) Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol 18, 240-245 crossref(new window)

Gils A and Declerck PJ (2004) The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors. Thromb Haemost 91, 425-437

Schroder WA, Major L and Suhrbier A (2011) The role of SerpinB2 in immunity. Crit Rev Immunol 31, 15-30 crossref(new window)

Hwa V, Oh Y and Rosenfeld RG (1999) The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20, 761-787

Stewart CE, Bates PC, Calder TA, Woodall SM and Pell JM (1993) Potentiation of insulin-like growth factor-I (IGF-I) activity by an antibody: supportive evidence for enhancement of IGF-I bioavailability in vivo by IGF binding proteins. Endocrinology 133, 1462-1465 crossref(new window)

Clemmons DR, Busby WH, Arai T et al (1995) Role of insulin-like growth factor binding proteins in the control of IGF actions. Prog Growth Factor Res 6, 357-366 crossref(new window)

Orjalo AV, Bhaumik D, Gengler BK, Scott GK and Campisi J (2009) Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc Natl Acad Sci U S A 106, 17031-17036 crossref(new window)

Kim YM, Byun HO, Jee BA et al (2013) Implications of time-series gene expression profiles of replicative senescence. Aging Cell 12, 622-634 crossref(new window)

Chow FL and Fernandez-Patron C (2007) Many membrane proteins undergo ectodomain shedding by proteolytic cleavage. Does one sheddase do the job on all of these proteins? IUBMB Life 59, 44-47 crossref(new window)

Hayashida K, Bartlett AH, Chen Y and Park PW (2010) Molecular and cellular mechanisms of ectodomain shedding. Anat Rec (Hoboken) 293, 925-937 crossref(new window)

Athauda G, Giubellino A, Coleman JA et al (2006) c-Met ectodomain shedding rate correlates with malignant potential. Clin Cancer Res 12, 4154-4162 crossref(new window)

Acosta JC and Gil J (2009) A role for CXCR2 in senescence, but what about in cancer? Cancer Res 69, 2167-2170 crossref(new window)

Freund A, Orjalo AV, Desprez PY and Campisi J (2010) Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 16, 238-246 crossref(new window)

Guo H, Liu Z, Xu B et al (2013) Chemokine receptor CXCR2 is transactivated by p53 and induces p38-mediated cellular senescence in response to DNA damage. Aging Cell 12, 1110-1121 crossref(new window)

Kenyon C, Chang J, Gensch E, Rudner A and Tabtiang R (1993) A C. elegans mutant that lives twice as long as wild type. Nature 366, 461-464 crossref(new window)

Elzi DJ, Lai Y, Song M, Hakala K, Weintraub ST and Shiio Y (2012) Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 cascade regulates stressinduced senescence. Proc Natl Acad Sci U S A 109, 12052-12057 crossref(new window)

Micutkova L, Diener T, Li C et al (2011) Insulin-like growth factor binding protein-6 delays replicative senescence of human fibroblasts. Mech Ageing Dev 132, 468-479 crossref(new window)